• Blog
  • Finasteride Market Analysis | 2023-2028

    Finasteride Market Analysis | 2023-2028

    Finasteride Market Analysis | 2023-2028
    Report code - SRAM512 Delivery - 2 Weeks
    Finasteride Market Size, Share, Trend, Forecast & Industry Analysis: 2023-2028
    See more...

    Market Insights

    The Finasteride Market was estimated at US$ 102.25 million in 2022 and is expected to grow at a CAGR of 2.9% during 2023-2028 to reach US$ 121.6 million by 2028.

    Wish to get a free sample? Register Here

    What is Finasteride?

    Finasteride is a medication widely used for two main things: treating an enlarged prostate (known as benign prostatic hyperplasia) and tackling male pattern baldness (androgenetic alopecia). Well, it plays the role of a 5-alpha-reductase inhibitor, basically putting a halt to the conversion of testosterone into dihydrotestosterone (DHT). Now, DHT is a hormone linked to prostate enlargement and hair loss. So, by keeping DHT levels in check, finasteride helps ease urinary issues related to a swollen prostate and even encourages hair to make a comeback for those dealing with the follicle-challenged situation.

    Market Drivers

    The prime factor that is contributing to the demand for finasteride is the constantly rising cases of prostate cancer. Also, the consumer’s preference for hair treatment and increasing expenditure on hair care products to further drive the market.

    Segments Analysis

    Want to get more details about the segmentations? Register Here

    By Product Type

    The market is segmented into 1mg and 5mg. The 1mg segment dominated the finasteride market. Increasing cases of male baldness due to genetics, illness, stress, and medicine side effects foster the demand for these products. Also, the rising aging population in countries such as Germany, Italy, the UK, and France has created huge demand for hair loss treatment products.

    By Application Type

    The finasteride market is segmented into prostate treatment and hair treatment. Prostate treatment application is likely to grow at a faster pace during the forecast period, owing to increasing cases of prostate-related diseases.

    Regional Analysis

    In terms of regions, North America is the major market for finasteride. The products are widely used in the US for the treatment of male baldness and prostate-related diseases. Also, the North American region has a strong presence of major finasteride manufacturers, including Merck & Co., Inc., Teva Pharmaceutical Industries Ltd, and Cipla Limited.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    Some of the major finasteride manufacturers are-

    • Cipla Limited
    • Dr. Reddy's Laboratories
    • Guangdong Eashu Pharmaceutical Co., Ltd
    • Henan Topfond Pharmaceutical Co., Ltd
    • Merck & Co., Inc.
    • Novartis AG
    • Relonchem Limited
    • Shandong Renhetang Pharmaceutical Co., Ltd
    • Teva Pharmaceutical Industries Ltd
    • Zhejiang CONBA Pharmaceutical Co., Ltd.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Finasteride Market 

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Who are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players).
    • SWOT analysis of key players (up to 3 players).

    Market Segmentation

    • Current market segmentation of any one of the product types by application type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The Finasteride Market is expected to grow at a CAGR of 2.9% during 2023-2028.

    Cipla Limited, Dr. Reddy's Laboratories, Guangdong Eashu Pharmaceutical Co., Ltd, Henan Topfond Pharmaceutical Co., Ltd, Merck & Co., Inc., Novartis AG, and Relonchem Limited, Shandong Renhetang Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd, and Zhejiang CONBA Pharmaceutical Co., Ltd are among the key players in the finasteride market.

    The Finasteride Market is expected to reach US$ 121.6 million by 2028.

    Prostate treatment applications are likely to grow at a faster pace in the finasteride market in the coming years.

    The prime factor that is contributing to the demand for finasteride is the constantly rising cases of prostate cancer.